What is the 13F Pro Quality Score for CTEV?

13F Pro ranks Claritev Corp (CTEV) on the 13F Pro Quality Score, a 0–100 composite of 32 fundamental signals including return on invested capital, free cash flow consistency, balance-sheet strength, earnings quality, growth durability, and valuation discipline. The score refreshes after each 10-K and 10-Q filing on SEC EDGAR. View CTEV's current score at https://13fpro.ai/research/CTEV (free sign-up required for the full ranking).

Where does 13F Pro source CTEV data?

All Claritev Corp fundamentals and ownership data come directly from SEC EDGAR. Claritev Corp files with the SEC under CIK 1793229. 13F Pro ingests XBRL financial facts from 10-K and 10-Q filings, Form 13F-HR institutional holdings, and Form 4 insider transactions, with no third-party rewrites or estimates.

What sector is CTEV in?

Claritev Corp (CTEV) is classified in the Industrials sector. 13F Pro publishes sector-level fund flow analysis and quality leaders at https://13fpro.ai/research/sector/industrials.

How often is CTEV research updated on 13F Pro?

CTEV's fundamentals refresh within hours of each new 10-K or 10-Q filing on SEC EDGAR. Institutional ownership updates after each quarterly 13F filing window. Insider transactions update after each Form 4 filing. The 13F Pro Quality Score recalculates after every fundamentals refresh.

Claritev Corp(CTEV)Stock Analysis

AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →

Industrials →NYSE

Institutional-grade research for retail investors

SEC EDGAR: CIK 1793229 CTEV stock profile & AI dashboard →

13F Pro Quality Score

27.6/100

Rank #2,463 of 2,879 stocks

View Industrials peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Aug 14, 2026.

Revenue Growth

34.8/100

Profitability

15.4/100

Balance Sheet

23.0/100

Earnings Quality

30.0/100

Free Cash Flow

16.3/100

Institutional Flow

22.0/100

Revenue Scale

48.7/100

Dilution Risk

34.6/100

CTEV Stock Analysis & AI Quality Score

AI stock analysis and institutional research for Claritev Corp (CTEV), a Industrials sector company. 13F Pro's AI-powered ranking engine scores CTEV at 27.6/100 on a 32-signal composite quality model, placing it at rank #2,463 of 2,879 stocks — the bottom half of the AI-ranked universe. Areas of concern include profitability (15.4) and free cash flow (16.3), which score below median versus the broader universe. Shareholder dilution risk is elevated at 34.6/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q1 2026), Claritev Corp reports quarterly revenue of $244.7M, net income of $-73.6M, an operating margin of 2.7%. Top institutional holders of CTEV by reported 13-F value include H&F Corporate Investors VIII, Ltd., ARES MANAGEMENT, Arini Captial Management Ltd, based on the most recent SEC filings. CTEV trades on the NYSE exchange and files with the SEC under CIK 1793229. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate CTEV daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Claritev Corp directly from SEC EDGAR. Claritev Corp's 13F Pro composite quality score has ranged between 8 and 36 since 2024, currently 27.6 — a stable long-term trajectory across 41 quarterly and live scoring snapshots.

✦

Fun facts about Claritev Corp

Quirks, history, and lore behind CTEV — the kind of stuff that makes a stock memorable.

1
The Basics
U.S. technology services company · operates in the healthcare data and analytics space · listed on NYSE · headquartered in Tennessee.
2
The Numbers
Processes hundreds of millions of medical claims annually and generates revenue in the low billions of dollars — not glamorous, but the plumbing of healthcare billing runs through it.
3
The History
Born from a decades-long lineage in healthcare cost management, the company was formerly known as MultiPlan before rebranding as it repositioned its identity for investors.
4
The Secret
Its core business is payment accuracy and cost containment — essentially convincing payers and insurers to pay less on claims, and taking a cut of the savings.
5
The Lore
The company went public via a high-profile SPAC merger — one of the largest blank-check deals of its era — then faced scrutiny when a short-seller called its customer concentration into serious question.
6
The Giveaway
Rebranded from MultiPlan to a new name in 2024, trading under ticker CTEV — the self-described connective tissue of healthcare payment infrastructure.

▶ Think you know your stocks? Play the Daily Ticker

Revenue

Q1 2026

$244.7M

Net Income

Q1 2026

$-73.6M

Free Cash Flow

Q1 2026

$-92.5M

Operating Margin

Q1 2026

2.7%

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro+

Revenue

+3.7% YoY

$965.4MFY 2025

FY22 $1.08BFY23 $961.5MFY24 $930.6MFY25 $965.4M

Net Income

+82.7% YoY

$-284.3MFY 2025

FY22 $-572.9MFY23 $-91.7MFY24 $-1.65BFY25 $-284.3M

Operating Income

+102.1% YoY

$28.8MFY 2025

FY22 $-362.7MFY23 $162.0MFY24 $-1.39BFY25 $28.8M

EPS (Diluted)

+83.0% YoY

$-17.30FY 2025

FY22 $-0.90FY23 $-5.69FY24 $-101.92FY25 $-17.30

Total Assets

-5.1% YoY

$4.89BFY 2025

FY22 $7.37BFY23 $6.96BFY24 $5.15BFY25 $4.89B

Total Debt

+1.0% YoY

$4.63BFY 2025

FY22 $4.84BFY23 $4.61BFY24 $4.58BFY25 $4.63B

Op. Cash Flow

+9.0% YoY

$117.3MFY 2025

FY22 $372.4MFY23 $171.7MFY24 $107.6MFY25 $117.3M

Metric	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2018
Revenue	$965.4M +3.7%	$930.6M -3.2%	$961.5M -10.9%	$1.08B -3.4%	$1.12B +7.4%	$1.04B
Net Income	$-284.3M +82.7%	$-1.65B -1694.9%	$-91.7M +84.0%	$-572.9M -661.2%	$102.1M +181.8%	$36.2M
Operating Income	$28.8M +102.1%	$-1.39B -958.1%	$162.0M +144.7%	$-362.7M -193.9%	$386.1M -9.7%	$427.5M
EPS (Diluted)	$-17.30 +83.0%	$-101.92 -1691.2%	$-5.69 -532.2%	$-0.90 -662.5%	$0.16	—
Total Assets	$4.89B -5.1%	$5.15B -26.0%	$6.96B -5.5%	$7.37B -10.3%	$8.22B	—
Total Debt	$4.63B +1.0%	$4.58B -0.7%	$4.61B -4.6%	$4.84B -3.0%	$4.99B	—
Operating Cash Flow	$117.3M +9.0%	$107.6M -37.3%	$171.7M -53.9%	$372.4M -8.0%	$404.7M +38.4%	$292.3M

AI Insight: CTEV Financial Trends

Claritev remains deeply loss-making with $4.6B in debt and equity now negative $241M, despite operating losses narrowing sharply from the 2024 lows.

• Operating loss improved dramatically from -$524M in Q2 2024 to near breakeven, ranging -$8M to +$17M across Q2 2025–Q1 2026.

• Revenue grew modestly from $230M in Q3 2024 to $247M in Q4 2025, a ~7% increase over six quarters.

• Equity has deteriorated from $603M in Q2 2024 to -$241M in Q1 2026, reflecting sustained net losses eroding the balance sheet.

• Total debt crept higher every quarter, rising from $4,524M in Q2 2024 to $4,639M in Q1 2026 — eight consecutive increases.

⚠ Operating cash flow is volatile and turned negative (-$46M) in Q1 2026 after positive $66M in Q4 2025 — consistency is unproven.

⚠ Negative equity of -$241M combined with $4.6B debt raises near-term solvency concerns; covenant or refinancing risk warrants monitoring.

⚠ Operating income has stalled between -$8M and +$17M for four straight quarters — watch for sustained positive territory.

AI Insight: CTEV Ratio Trends

Claritev remains deeply unprofitable with net margins persistently negative, though operating margins have stabilized near breakeven after a catastrophic Q3 2024 collapse.

• Operating margin recovered sharply from -146.7% in Q3 2024 to a peak of 6.9% in Q2 2025, but has since slipped back to 2.7% in Q1 2026.

• Net profit margin has remained deeply negative every quarter, ranging from -25.9% in Q2 2025 to -169.8% in Q3 2024, signaling persistent below-the-line drag.

• ROIC turned positive in Q1 2025 at 0.9%, peaked at 1.5% in Q2 2025, then fell back to -0.7% in Q4 2025 before recovering to 0.6% in Q1 2026.

• ROA has stayed negative throughout, most recently at -6.1% in Q1 2026, indicating assets are not generating positive returns.

⚠ D/E spiked to 21.79x in Q3 2024 — leverage data is sparse but that reading signals extreme balance sheet stress worth tracking.

⚠ Operating margin turned negative again at -3.1% in Q4 2025; Q1 2026 recovery to 2.7% is fragile and needs confirmation.

⚠ The persistent gap between operating margin and net margin suggests heavy interest or non-operating costs eroding any operating progress.

Get alerted when CTEV's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for Claritev Corp including:

SEC EDGAR filings (10-K, 10-Q, 8-K)

XBRL financial facts (revenue, EPS, margins)

Insider transactions (Form 4)

Institutional 13F holdings

Quality rankings (32 signals)

AI analyst debates & daily meetings

Historical financial trends

Peer comparison & sector analysis

Top Institutional Holders of CTEV

H&F Corporate Investors VIII, Ltd.
$63.5M3,887,858 sh
ARES MANAGEMENT LLC
$30.4M1,863,105 sh
Arini Captial Management Ltd
$25.1M1,534,687 sh
PUBLIC INVESTMENT FUND
$20.9M1,281,250 sh
Beach Point Capital Management LP
$13.0M795,346 sh
BlackRock, Inc.
$9.6M588,003 sh
CPV Partners, LLC
$8.1M495,258 sh
VANGUARD CAPITAL MANAGEMENT LLC
$7.0M430,068 sh
CASPIAN CAPITAL LP
$5.8M356,250 sh
PRUDENTIAL FINANCIAL INC
$5.8M353,744 sh

Fund	Value	Shares
H&F Corporate Investors VIII, Ltd.	$63.5M	3,887,858
ARES MANAGEMENT LLC	$30.4M	1,863,105
Arini Captial Management Ltd	$25.1M	1,534,687
PUBLIC INVESTMENT FUND	$20.9M	1,281,250
Beach Point Capital Management LP	$13.0M	795,346
BlackRock, Inc.	$9.6M	588,003
CPV Partners, LLC	$8.1M	495,258
VANGUARD CAPITAL MANAGEMENT LLC	$7.0M	430,068
CASPIAN CAPITAL LP	$5.8M	356,250
PRUDENTIAL FINANCIAL INC	$5.8M	353,744

More Industrials Companies

View all Industrials →

AADX

Applied Aerospace & Defense, Inc.

AAL

American Airlines Group Inc.

AAON

AAON, INC.

ABM

ABM INDUSTRIES INC /DE/

ACA

Arcosa, Inc.

ACHR

Archer Aviation Inc.

ACLS

AXCELIS TECHNOLOGIES INC

ACMR

ACM Research, Inc.

Put CTEV on your watchlist

Track score changes the day Claritev Corp files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Popular Research

AAPL

Apple

MSFT

Microsoft

NVDA

NVIDIA

GOOG

Alphabet

AMZN

Amazon

Is CTEV a good stock to buy?

13F Pro's AI-powered analysis of Claritev Corp (CTEV) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Industrials sector (listed on NYSE). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for CTEV are available on the CTEV stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.

Which hedge funds own CTEV?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling CTEV. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of Claritev Corp's investment landscape.